Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion description "[These data demonstrate that heterodimerization of erbB2/erbB3 is a prerequisite for erbB2 tyrosine kinase activation; and elevated expression of erbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells via PI-3K/Akt/mTOR signaling pathway-dependent upregulation of Survivin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion evidence source_evidence_literature NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion SIO_000772 20498641 NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion wasDerivedFrom befree-2016 NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_assertion wasGeneratedBy ECO_0000203 NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.
- befree-2016 importedOn "2016-02-19" NP814306.RAerI5DewZ0DUpR9I3DgBO-WYyFb5dYMdm2_SmdHOTzmY130_provenance.